Vanguard Group Inc Shattuck Labs, Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,303,000 shares of STTK stock, worth $8.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,303,000

Previous 1,819,926 26.54%

Holding current value

$8.04 Million

Previous $16.3 Million 45.37%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.56 - $11.18 $1.72 Million - $5.4 Million	483,074 Added 26.54%	2,303,000 $8.89 Million
Q1 2024 May 10, 2024	BUY	$7.37 - $10.09 $3.71 Million - $5.07 Million	502,860 Added 38.18%	1,819,926 $16.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.37 - $7.24 $196,364 - $1.04 Million	143,332 Added 12.21%	1,317,066 $9.39 Million
Q3 2023 Nov 14, 2023	BUY	$1.42 - $3.16 $7,295 - $16,236	5,138 Added 0.44%	1,173,734 $1.78 Million
Q2 2023 Aug 14, 2023	SELL	$2.52 - $3.66 $16,443 - $23,881	-6,525 Reduced 0.56%	1,168,596 $3.65 Million
Q1 2023 May 15, 2023	BUY	$2.5 - $4.72 $27,600 - $52,108	11,040 Added 0.95%	1,175,121 $3.45 Million
Q4 2022 Feb 10, 2023	BUY	$1.96 - $3.26 $26,128 - $43,459	13,331 Added 1.16%	1,164,081 $2.68 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $4.59 $530,817 - $902,389	-196,599 Reduced 14.59%	1,150,750 $4.67 Million
Q1 2022 May 13, 2022	SELL	$4.22 - $8.89 $387,788 - $816,928	-91,893 Reduced 6.38%	1,347,349 $5.74 Million
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $72,790 - $183,543	8,707 Added 0.61%	1,439,242 $12.2 Million
Q3 2021 Nov 12, 2021	BUY	$17.57 - $28.95 $3.47 Million - $5.72 Million	197,549 Added 16.02%	1,430,535 $29.2 Million
Q2 2021 Aug 13, 2021	BUY	$24.14 - $37.68 $29.8 Million - $46.5 Million	1,232,986 New	1,232,986 $35.7 Million

Others Institutions Holding STTK

# of Institutions

Shares Held

26.8M

Call Options Held

3.1K

Put Options Held

23.9K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $148M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Shattuck Labs, Inc. Transaction History